Effect of urokinase thrombolytic therapy for optic artery and retinal artery occlusion caused by facial microinjection with hyaluronic acid and spontaneous retinal artery occlusion / 中华眼底病杂志

Objective To compare the clinical effects ofurokinase thrombolytic therapy for optic artery occlusion (OAO) and retinal artery occlusion (RAO) caused by facial microinjection with hyaluronic acid and spontaneous RAO.Methods From January 2014 to February 2018,22 eyes of 22 patients with OAO and RAO caused by facial microinjection of hyaluronic acid who received treatment in Xi'an Fourth Hospital were enrolled in this retrospective study (hyaluronic acid group).Twenty-two eyes of 22 patients with spontaneous RAO were selected as the control group.The BCVA examination was performed using the international standard visual acuity chart,which was converted into logMAR visual acuity.FFA was used to measure arm-retinal circulation time (A-Rct) and filling time of retinal artery and its branches (FT).Meanwhile,MRI examination was performed.There were significant differences in age and FT between the two groups (t=14.840,3.263;P=0.000,0.003).The differecens of logMAR visual acuity,onset time and A-Rct were not statistically significant between the two groups (t=0.461,0.107,1.101;P=0.647,0.915,0.277).All patients underwent urokinase thrombolysis after exclusion of thrombolytic therapy.Among the patients in the hyaluronic acid group and control group,there were 6 patients of retrograde ophthalmic thrombolysis via the superior pulchlear artery,6 patients of retrograde ophthalmic thrombolysis via the internal carotid artery,and 10 patients of intravenous thrombolysis.FFA was reviewed 24 h after treatment,and A-Rct and FT were recorded.Visual acuity was reviewed 30 days after treatment.The occurrence of adverse reactions during and after treatment were observed.The changes of logMAR visual acuity,A-Rct and FT before and after treatment were compared between the two groups using ttest.Results At 24 h after treatment,the A-Rct and FT of the hyaluronic acid group were 21.05 ± 3.42 s and 5.05± 2.52 s,which were significantly shorter than before treatment (t=4.569,2.730;P=0.000,0.000);the A-Rct and FT in the control group were 19.55 ± 4.14 s and 2.55± 0.91 s,which were significantly shorter than before treatment (t=4.114,7.601;P=0.000,0.000).There was no significant difference in A-Rct between the two groups at 24 h after treatment (t=l.311,P=0.197).The FT difference was statistically significant between the two groups at 24 h after treatment (t=4.382,P=0.000).There was no significant difference in the shortening time of A-Rct and FT between the two groups (t=0.330,0.510;P=0.743,0.613).At 30 days after treatment,the logMAR visual acuity in the hyaluronic acid group and the control group were 0.62± 0.32 and 0.43± 0.17,which were significantly higher than those before treatment (t=2.289,5.169;P=0.029,0.000).The difference of logMAR visual acuity between the two groups after treatment was statistically significant (t=2.872,P=0.008).The difference in logMAR visual acuity before and after treatment between the two groups was statistically significant (t=2.239,P=0.025).No ocular or systemic adverse reactions occurred during or after treatment in all patients.Conclusions Urokinase thrombolytic therapy for OAO and RAO caused by facial microinjection with hyaluronic acid and spontaneous RAO is safe and effective,with shortening A-Rct,FT and improving visual acuity.However,the improvement of visual acuity after treatment of OAO and RAO caused by facial microinjection with hyaluronie acid is worse than that of spontaneous RAO.

Effect of urokinase thrombolytic therapy for optic artery and retinal artery occlusion caused by facial microinjection with hyaluronic acid and spontaneous retinal artery occlusion / 中华眼底病杂志

Objective@#To compare the clinical effects of urokinase thrombolytic therapy for optic artery occlusion (OAO) and retinal artery occlusion (RAO) caused by facial microinjection with hyaluronic acid and spontaneous RAO.@*Methods@#From January 2014 to February 2018, 22 eyes of 22 patients with OAO and RAO caused by facial microinjection of hyaluronic acid who received treatment in Xi'an Fourth Hospital were enrolled in this retrospective study (hyaluronic acid group). Twenty-two eyes of 22 patients with spontaneous RAO were selected as the control group. The BCVA examination was performed using the international standard visual acuity chart, which was converted into logMAR visual acuity. FFA was used to measure arm-retinal circulation time (A-Rct) and filling time of retinal artery and its branches (FT). Meanwhile, MRI examination was performed. There were significant differences in age and FT between the two groups (t=14.840, 3.263; P=0.000, 0.003). The differecens of logMAR visual acuity, onset time and A-Rct were not statistically significant between the two groups (t=0.461, 0.107, 1.101; P=0.647, 0.915, 0.277). All patients underwent urokinase thrombolysis after exclusion of thrombolytic therapy. Among the patients in the hyaluronic acid group and control group, there were 6 patients of retrograde ophthalmic thrombolysis via the superior pulchlear artery, 6 patients of retrograde ophthalmic thrombolysis via the internal carotid artery, and 10 patients of intravenous thrombolysis. FFA was reviewed 24 h after treatment, and A-Rct and FT were recorded. Visual acuity was reviewed 30 days after treatment. The occurrence of adverse reactions during and after treatment were observed. The changes of logMAR visual acuity, A-Rct and FT before and after treatment were compared between the two groups using ttest.@*Results@#At 24 h after treatment, the A-Rct and FT of the hyaluronic acid group were 21.05±3.42 s and 5.05±2.52 s, which were significantly shorter than before treatment (t=4.569, 2.730; P=0.000, 0.000); the A-Rct and FT in the control group were 19.55±4.14 s and 2.55±0.91 s, which were significantly shorter than before treatment (t=4.114, 7.601; P=0.000, 0.000). There was no significant difference in A-Rct between the two groups at 24 h after treatment (t=1.311, P=0.197). The FT difference was statistically significant between the two groups at 24 h after treatment (t=4.382, P=0.000). There was no significant difference in the shortening time of A-Rct and FT between the two groups (t=0.330, 0.510; P=0.743, 0.613). At 30 days after treatment, the logMAR visual acuity in the hyaluronic acid group and the control group were 0.62±0.32 and 0.43±0.17, which were significantly higher than those before treatment (t=2.289, 5.169; P=0.029, 0.000). The difference of logMAR visual acuity between the two groups after treatment was statistically significant (t=2.872, P=0.008). The difference in logMAR visual acuity before and after treatment between the two groups was statistically significant (t=2.239, P=0.025). No ocular or systemic adverse reactions occurred during or after treatment in all patients.@*Conclusions@#Urokinase thrombolytic therapy for OAO and RAO caused by facial microinjection with hyaluronic acid and spontaneous RAO is safe and effective, with shortening A-Rct, FT and improving visual acuity. However, the improvement of visual acuity after treatment of OAO and RAO caused by facial microinjection with hyaluronic acid is worse than that of spontaneous RAO.

Neovascularization of the Optic Disc Associated with Acute Ophthalmic Artery Obstruction

PURPOSE: It has been reported that neovascularization of the optic disc (NVD) occurs in ocular ischemic syndrome, sickle cell hemoglobinopathy, ocular sarcoidosis, Eales' disease, and central retinal artery occlusion. However, NVD in acute ophthalmic artery occlusion had not been reported. Therefore, we report one unusual case of NVD in acute ophthalmic artery obstruction. METHODS: A 56 year-old man with complaint of abrupt decrease of visual acuity and periorbital discomfort underwent medical history taking, periorbital examination, fundus examination, and fluorescein angiography. He was followed up for 5 months RESULTS: Fundus examination showed segmentation of blood flow and diffuse retinal whitish opacity on the posterior pole around the center of the macula, without any cherry red spots in the perifoveal area. Fluorescein angiography showed a marked filling delay in the nasal retinal and choroidal circulations with a definite watershed zone involving the peripapillary choroid and macula. The retinal arteries filling and arteriovenous transit time were delayed. There was no light-perception vision and low intraocular pressure. Diabetes was found on systemic examination. Five weeks later, NVD and choroidal atrophy around the optic disc were detected. Panretinal photocoagulation was performed for the regression of NVD. NVD was regressed, but recurred.

Incomplete Central Retinal Artery Occlusion

Ophthalmic artery occlusion results in a circulatory disturbance of both central retinal artery and posterior ciliary arteries, causing an ischemia of retina and choroid. On fundus examination, white retinal opacification and cherry-red spot can be noted if central retinal artery occlusion is not associated with lateral posterior ciliary artery obstruction. If, however, central retinal artery occlusion is asssociated with lateral posterior ciliary artery obstruction, the cherry-red spot is no longer visible. The author experienced five patients with a mottled loss of retinal transparency in the macular region. Combined central retinal artery occlusion with obstruction of both medial posterior ciliary artery and lateral posterior ciliary artery were observed in two patients, both central retinal artery occlusion and medial posterior ciliary obstruction in two patients, and central retinal artery occlusion alone in one patient. The fundus findings in all five cases are compatible with an incomplete central retinal artery occlusion which in at least four cases was associated with evidence of choroidal vascular obstruction.

Visual Improvement following Acute Obstruction of the Retinal and Choroidal Blood Flows

The prognosis for useful vision after central retinal artery obstruction is generally considered poor, except in those cases with a patent cilioretinal artery. When the choroidal circulation is affected as well in the form of an ophthalmic artery obstruction, characteristically the visual loss is more severe and the retinal whitening is more intense and, the cherry-red spot may be present. We report a patient with partial visual improvement following acute obstruction of the retinal and choroidal circulations more than three hours.